Table of Contents. Last updated by CLO: 5/8/2013 1

Size: px
Start display at page:

Download "Table of Contents. Last updated by CLO: 5/8/2013 1"

Transcription

1 Table of Contents Drug-induced liver injury algorithm - Cases... 2 Drug-induced liver injury algorithm - Controls Summary of drug-induced liver injury algorithm Terminology Threshold laboratory values Notes... 5 Appendix 1: Expanded list of medications Last updated by CLO: 5/8/2013 1

2 Drug-induced liver injury algorithm - Cases Note 1 Note 9 Note 10 Biobank patients (> 1 years old inpatients) yes no Coded data A2. Exposure to drug 3 mo prior to liver injury diagnosis? Exclude Exclude no Note 2 Note 8 A1. Diagnosed with liver injury? no Coded data NLP Coded data B. Chronic liver injury? yes Note 3 Note 5 C1. Peak ALP >= 2x ULN? Note 3 Note 6 C2. Peak ALT >= 3x ULN? Note 4 OR NLP yes Note 3 Note 3 Note 6 Note 10 Note 5 Note 11 C4. Peak ALP within 6mo after med >= 2x ULN? yes no C8. ALP >= 2x ULN within 1mo prior to med? C9. ALT >= 3x ULN within 1mo prior to med? C10. Bilirubin yes >= 2x ULN within 1mo prior to yes med? Exclude C5. Peak ALT within 6mo after med >= 5x ULN? yes Note 14 OR Exclude yes Exclude NLP yes Consider chronicity no no AND yes Coded data D. **Other diagnoses? NLP Note 13 Note 15 Notes yes Note 3 Note 7 Note 3 Note 6 Note 3 Note 7 no C3. Peak Bilirubin >= 2x ULN? C6. Peak ALT within 6mo after med >= 3x ULN? C7. Peak Bilirubin within 6mo after med >= 2x ULN? Exclude no Exclude no Exclude no Exclude Patients meeting drug induced liver injury criteria **Selection of other diagnoses may be institution specific Last updated by CLO: 5/8/2013 2

3 Drug-induced liver injury algorithm - Controls Exclude Exclude yes no Note 2 Coded data Note 30 Coded data Biobank patients (> 1 years old inpatients) E1. Diagnosed with liver injury? no E2. Exposure to drug? NLP NLP yes Note 15 Notes Note 31 Coded data Patients meeting criteria for control population no E3. **Other diagnoses? NLP yes **Selection of other diagnoses may be institution specific Exclude Last updated by CLO: 5/8/2013 3

4 1. Summary of drug-induced liver injury algorithm Inclusion criteria A. Suspect DILI? (NOTE: baseline population is institution specific. See institution implementation details) Liver injury AND Exposure to drug (NOTE: medications are institution specific. See institution implementation details) Temporal relationship of exposure to drug and liver injury diagnosis. i. Exposure to drug within 3 months prior to liver injury diagnosis B. Acute liver injury? C. Does it reach the threshold to qualify as DILI? ALP >=2x ULN OR ALT >= 5x ULN OR (ALT>= 3xULN AND Bilirubin >= 2x ULN) Temporal relationship of laboratory measurements and acute liver injury diagnosis. i. Normal laboratory measurements prior to exposure to drug. ii. Laboratory measurements reach threshold for DILI following drug administration. Exclusion criteria D. Patients with other diagnoses (cancer, gallbladder disease, pancreatic disease, heart failure, alcohol abuse/liver damage/toxic effects, HIV infection, rheumatoid arthritis, sarcoidosis, systemic lupus, viral hepatitis, sclerosing cholangitis, chronic liver disease, organ transplantation, liver operation, death, overdose). (NOTE: excluded diagnoses are institution specific. See institution implementation details). Ref: Aithal, G.P., et al., Case Definition and Phenotype Standardization in Drug-Induced Liver Injury. Clin Pharmacol Ther Jun;89(6): Terminology ULN = Upper limit of normal ALT = Alanine aminotransferase ALP = Alkaline phosphatase 3. Threshold laboratory values ALT ULN: 45 U/L (international units/liter) ALP ULN: 120 U/L (international units/liter) Bilirubin ULN: 40 umol/l (2.34 mg/dl) Source: International Serious Adverse Events Consortium (isaec) DILI study protocol. (NOTE: Use of isaec threshold values is institution specific. See institution implementation details.) Last updated by CLO: 5/8/2013 4

5 4. Notes Note 1 Baseline population is institution specific. See institution implementation details. Note 2 Acute liver injury related ICD-9 diagnosis and procedure codes and UMLS CUIs applied in algorithm. Acute liver injury diagnosis is determined by either of the following (also see Figure 1): a. ICD-9 code for acute liver injury diagnosis. b. Acute liver injury related diagnosis mentioned in clinical notes using NLP. (NOTE: Specific notes and use of NLP is institution specific. See institution implementation details.) Acute liver injury related diagnoses ICD-9 UMLS CUIs and procedures codes Disorders of bilirubin excretion C Acute and subacute necrosis of the 570* C , C , C liver Hepatic coma (hepatorenal syndrome) C Hepatorenal syndrome 572.4* C Other disorders of the liver, including chemical or drug induced Other specified disorders of biliary tract C Jaundice, unspecified, not of newborn C Hepatomegaly 789.1* C Nonspecific elevation of transaminase or lactic dehydrogenase levels 790.4* C * C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C Abnormal liver function test results 794.8* C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C , C * reflects extra digits, covering any subcategory of that code. Ref: Ryan, P., et al., Observational Medical Outcomes Partnership Health Outcomes of Definitions, in Observational Medical Outcomes Partnership Query of patient medical records for acute liver injury related NLP applied to clinical notes to identify patients with acute liver injury diagnosis Figure 1. The union of results from two methods to identify patients with acute liver injury. One approach uses structured data (e.g., ) and the other approach uses NLP applied to clinical notes. (NOTE: Specific notes and use of NLP is institution specific. See institution implementation details.) Last updated by CLO: 5/8/2013 5

6 Note 3 Assess total ALP, ALT and Bilirubin laboratory values. Note 4 For A1-Yes patients, we evaluate whether patients have peak ALP >= 2x ULN OR peak ALT >= 3x ULN OR peak Bilirubin >=2x ULN above threshold (for ULN values See Threshold laboratory values). We exclude patients that do not satisfy any of these criteria. Note 5 Include laboratory values associated with alkaline phosphatase (ALP) tests. ALP tests UMLS CUI Intestinal alkaline phosphatase measurement C Note 6 Include laboratory values associated with alanine aminotransferase (ALT) tests. ALT tests UMLS CUI Alanine Aminotransferase Measurement C Note 7 Include laboratory values associated with intravascular bilirubin tests. Intravascular Bilirubin tests UMLS CUI Serum bilirubin indirect C Note 8 For C1/C2/C3-Yes patients, we should consider chronicity for patients with any liver injury diagnosis. Chronic liver injury diagnosis is determined by either of the following: a. ICD-9 code for chronic liver injury diagnosis. b. Chronic liver injury related diagnosis mentioned in clinical notes using NLP. (NOTE: Specific notes and use of NLP is institution specific. See institution implementation details.) Chronic liver disease diagnosis description ICD-9 code Alcoholic fatty liver Chronic hepatitis Chronic hepatitis, unspecified Chronic persistent hepatitis Other chronic hepatitis Cirrhosis of liver without mention of alcohol Biliary cirrhosis Other chronic nonalcoholic liver disease Autoimmune hepatitis Unspecified Chronic Liver Disease without Mention of Alcohol Last updated by CLO: 5/8/2013 6

7 Note 9 For B-No patients, we exclude patients that were not administered (started on) a medication (see Note 10 for a list of medication preparations) within 3 months before the A1 diagnosis. Date of administration is estimated by both of the following (also see Figure 2): a. Date a new medication is ordered. b. Date medication is mentioned in clinical note using NLP. (NOTE: Specific notes and use of NLP is institution specific. See institution implementation details.) Date of medication administration estimated by date medication ordered Date of medication administration estimated by date mentioned in patient clinical notes (using NLP) Figure 2. The union of results from two methods to determine whether date of medication administration is within 3 months before acute liver injury diagnosis. One approach uses structured data (e.g., institution specific codes for medications) and the other approach uses NLP applied to clinical notes. (NOTE: Specific notes and use of NLP is institution specific. See institution implementation details.) Note 10 Consider any of the following medication preparations: ciprofloxacin, clinafloxacin, levofloxacin, moxifloxacin, norfloxacin, ofloxacin, sparfloxacin, trovafloxacin, isoniazid, phenytoin, amoxicillin, valproic acid, nitrofurantoin, trimethoprim, minocycline. Preparations UMLS CUIs Ciprofloxacin Preparations C Clinafloxacin Preparations C Levofloxacin Preparations C Minocycline C Moxifloxacin Preparations C Norfloxacin Preparations C Ofloxacin Preparations C Sparfloxacin C Trovafloxacin Preparations C Isoniazid Preparations C Phenytoin Preparations C Amoxicillin Preparations C Valproic Acid Preparations C Nitrofurantoin Preparations C Trimethoprim Preparations C Source of medications: Drug Induced Liver Injury Network (DILIN) study protocol. (NOTE: Selection of medications is site specific. Sites may select from common medications associated with liver toxicity e.g., See Appendix 1 for an expanded list of medications from LiverTox.nih.gov [02/11/2013], or consider any medication order. See institution implementation details). Note 11 For A2-Yes patients, we evaluate if peak ALP level within 6 months after medication administration >= 2x ULN (for ULN values See Threshold laboratory values). Note 12 For C4-No patients, we evaluate whether patients have peak ALT within 6 months after medication administration >= 5x ULN (for ULN values See Threshold Last updated by CLO: 5/8/2013 7

8 laboratory values). Note 13 For C5-No patients, we evaluate whether patients have peak ALT within 6 months after medication administration >= 3x ULN AND have Bilirubin within 6 months after medication administration >= 2x ULN (for ULN values See Threshold laboratory values). We exclude patients that do not satisfy both requirements. Note 14 For C4, C5, C6/C7-Yes patients, we evaluate whether patient lab values were elevated within 1 month prior to medication administration (ALP >= 2x ULN OR ALT >= 3x ULN OR Bilirubin >= 2x ULN; for ULN values see Threshold laboratory values). We exclude patients that satisfy any of these criteria. Note 15 For C8/C9/C10-No patients and E2-Yes patients, we evaluate whether patients had any the following other diagnoses: primary sclerosing cholangitis, chronic liver disease, allogeneic bone marrow transplantation, cancer, gallbladder disease, pancreatic disease, heart failure, alcohol abuse/liver damage/toxic effects, HIV infection, rheumatoid arthritis, sarcoidosis, systemic lupus, inflammatory bowel disease, viral hepatitis, sclerosing cholangitis, chronic liver disease, organ transplantation, liver operation, death, or overdose. Other diagnoses are determined by either of the following (also see Figure 3): a. ICD-9 code for other diagnoses. b. Other diagnosis mentioned in clinical note using NLP. (NOTE: Specific notes and use of NLP is institution specific. See institution implementation details.) Source of other diagnoses: International Serious Adverse Events Consortium (isaec) study protocol. (NOTE: Selection of other diagnoses is institution specific. See institution implementation details). Query of patient medical records for other diagnosis related NLP applied to clinical notes to identify patients with other diagnoses Figure 3. The union of results from two methods to identify patients with other diagnoses. One approach uses structured data (e.g., ) and the other approach uses NLP applied to clinical notes. (NOTE: Specific notes and use of NLP is institution specific. See institution implementation details.) Note 16 Include all diagnoses associated with cancer (755 terms) Cancer Descriptions Nevus, Non-Neoplastic Carcinoid Syndrome Malignant Neoplasm Disseminated Malignant Neoplasm Malignant Neoplasm Of Ill-Defined Sites Within The Lip And Oral Cavity Mal Neo Lip/Vermil Mal Neo Upper Vermilion Mal Neo Lower Vermilion Mal Neo Lip, Inner Mal Neo Upper Lip, Inner Last updated by CLO: 5/8/2013 8

9 Cancer Descriptions Mal Neo Lower Lip, Inner Malignant Neoplasm Of Commissure Of Lip Malignant Neoplasm Of Other Sites Of Lip Malignant Neoplasm Of Tongue, Unspecified Malignant Neoplasm Of Base Of Tongue Malignant Neoplasm Of Dorsal Surface Of Tongue Mal Neo Tip/Lat Tongue Mal Neo Ventral Tongue Malignant Neoplasm Of Anterior Two-Thirds Of Tongue, Part Unspecified Mal Neo Tongue Junction Malignant Neoplasm Of Lingual Tonsil Malignant Neoplasm Of Other Sites Of Tongue Malignant Neoplasm Of Salivary Gland, Unspecified Malignant Neoplasm Of Parotid Gland Malignant Neoplasm Of Submandibular Gland Malignant Neoplasm Of Sublingual Gland Malignant Neoplasm Of Other Major Salivary Glands Malignant Neoplasm Of Gum, Unspecified Malignant Neoplasm Of Upper Gum Malignant Neoplasm Of Lower Gum Malignant Neoplasm Of Other Sites Of Gum Malignant Neoplasm Of Mouth, Unspecified Malignant Neoplasm Of Cheek Mucosa Mal Neo Mouth Vestibule Malignant Neoplasm Of Palate, Unspecified Malignant Neoplasm Of Hard Palate Malignant Neoplasm Of Soft Palate Malignant Neoplasm Of Uvula Malignant Neoplasm Of Retromolar Area Malig Neoplasm Mouth Other Malignant Neoplasm Of Floor Of Mouth, Part Unspecified Malignant Neoplasm Of Anterior Portion Of Floor Of Mouth Malignant Neoplasm Of Lateral Portion Of Floor Of Mouth Malignant Neoplasm Of Other Sites Of Floor Of Mouth Mal Neo Pharynx Malignant Neoplasm Of Oropharynx, Unspecified Malignant Neopl Tonsil Mal Neo Tonsillar Fossa Malignant Neoplasm Of Tonsillar Pillars (Anterior) (Posterior) Malignant Neoplasm Of Vallecula Malignant Neoplasm Of Anterior Aspect Of Epiglottis Malignant Neoplasm Of Junctional Region Of Oropharynx Malignant Neoplasm Of Lateral Wall Of Oropharynx Malignant Neoplasm Of Posterior Wall Of Oropharynx Mal Neo Oropharynx Other Malignant Neoplasm Of Nasopharynx, Unspecified Malignant Neoplasm Of Superior Wall Of Nasopharynx Mal Neo Post Nasopharynx Mal Neo Lat Nasopharynx Mal Neo Ant Nasopharynx Mal Neo Nasopharynx Other Malignant Neoplasm Of Hypopharynx, Unspecified Malignant Neoplasm Of Postcricoid Region Of Hypopharynx Malignant Neoplasm Of Pyriform Sinus Malignant Neoplasm Of Aryepiglottic Fold, Hypopharyngeal Aspect Malignant Neoplasm Of Posterior Hypopharyngeal Wall Malignant Neoplasm Of Other Specified Sites Of Hypopharynx Malignant Neoplasm Of Waldeyer's Ring Last updated by CLO: 5/8/2013 9

10 Cancer Descriptions Malignant Neoplasm Of Other Sites Within The Lip And Oral Cavity Malignant Neoplasm Of Digestive System And Intra-Abdominal Organs Malignant Neoplasm Of Esophagus, Unspecified Malignant Neoplasm Of Cervical Esophagus Malignant Neoplasm Of Thoracic Esophagus Malignant Neoplasm Of Abdominal Esophagus Malignant Neoplasm Of Upper Third Of Esophagus Malignant Neoplasm Of Middle Third Of Esophagus Malignant Neoplasm Of Lower Third Of Esophagus Malignant Neoplasm Of Other Specified Part Of Esophagus Malignant Neoplasm Of Stomach, Unspecified Malignant Neoplasm Of Cardia Malignant Neoplasm Of Pylorus Malignant Neoplasm Of Pyloric Antrum Malignant Neoplasm Of Fundus Of Stomach Malignant Neoplasm Of Body Of Stomach Malignant Neoplasm Of Lesser Curvature Of Stomach, Unspecified Malignant Neoplasm Of Greater Curvature Of Stomach, Unspecified Malig Neopl Stomach Other Malignant Neoplasm Of Intestinal Tract, Part Unspecified Malignant Neoplasm Of Small Intestine, Unspecified Malignant Neoplasm Of Duodenum Malignant Neoplasm Of Jejunum Malignant Neoplasm Of Ileum Malignant Neoplasm Of Meckel's Diverticulum Mal Neo Small Bowel Other Malignant Neoplasm Of Colon, Unspecified Malignant Neoplasm Of Hepatic Flexure Malignant Neoplasm Of Transverse Colon Malignant Neoplasm Of Descending Colon Malignant Neoplasm Of Sigmoid Colon Malignant Neoplasm Of Cecum Malignant Neoplasm Of Appendix Vermiformis Malignant Neoplasm Of Ascending Colon Malignant Neoplasm Of Splenic Flexure Malignant Neoplasm Of Other Specified Sites Of Large Intestine Malignant Neoplasm Of Rectosigmoid Junction Malignant Neoplasm Of Rectum Malignant Neo Anus Malignant Neoplasm Of Anal Canal Mal Neo Rectum/Anus Other Malignant Neoplasm Of Liver, Not Specified As Primary Or Secondary Mal Neo Liver, Primary Mal Neo Intrahepat Ducts Malignant Neoplasm Of Biliary Tract, Part Unspecified Malignant Neoplasm Of Gallbladder Mal Neo Extrahepat Ducts Malignant Neoplasm Of Ampulla Of Vater Other Icd9 Malignant Neoplasm Of Gallbladder And Extrahepatic Bile Ducts Malignant Neoplasm Of Pancreas, Part Unspecified Malignant Neoplasm Of Head Of Pancreas Malignant Neoplasm Of Body Of Pancreas Malignant Neoplasm Of Tail Of Pancreas Malignant Neoplasm Of Pancreatic Duct Mal Neo Islet Langerhans Malignant Neoplasm Of Other Specified Sites Of Pancreas Mal Neo Retroperitoneum Malignant Neoplasm Of Peritoneum, Unspecified Last updated by CLO: 5/8/

11 Cancer Descriptions Mal Neo Peritoneum Other Malignant Neoplasm Of Spleen, Not Elsewhere Classified Malignant Neoplasm Of Other Sites Of Digestive System And Intra-Abdominal Organs Malignant Neoplasm Of Ill-Defined Sites Within The Respiratory System Malignant Neoplasm Of Upper Respiratory Tract, Part Unspecified Malignant Neoplasm Of Accessory Sinus, Unspecified Mal Neo Nasal Cavities Malig Neo Middle Ear Malignant Neoplasm Of Maxillary Sinus Malignant Neoplasm Of Ethmoidal Sinus Malignant Neoplasm Of Frontal Sinus Malignant Neoplasm Of Sphenoidal Sinus Malignant Neoplasm Of Other Accessory Sinuses Malignant Neoplasm Of Larynx, Unspecified Malignant Neoplasm Of Glottis Malignant Neoplasm Of Supraglottis Malignant Neoplasm Of Subglottis Mal Neo Cartilage Larynx Malignant Neo Larynx Other Malignant Neoplasm Of Bronchus And Lung, Unspecified Malignant Neo Trachea Malig Neo Main Bronchus Mal Neo Upper Lobe Lung Mal Neo Middle Lobe Lung Mal Neo Lower Lobe Lung Malignant Neoplasm Of Other Parts Of Bronchus Or Lung Malignant Neoplasm Of Pleura, Unspecified Malignant Neoplasm Of Parietal Pleura Malignant Neoplasm Of Visceral Pleura Malignant Neoplasm Of Other Specified Sites Of Pleura Malignant Neoplasm Of Mediastinum, Part Unspecified Malignant Neoplasm Of Thymus Malignant Neopl Heart Malignant Neoplasm Of Anterior Mediastinum Malignant Neoplasm Of Posterior Mediastinum Malignant Neoplasm Of Other Parts Of Mediastinum Other Icd9 Malignant Neoplasm Of Respiratory System And Intrathoracic Organs Malignant Neoplasm Of Bone And Articular Cartilage, Site Unspecified Malignant Neoplasm Of Bones Of Skull And Face, Except Mandible Malignant Neoplasm Of Mandible Malignant Neoplasm Of Vertebral Column, Excluding Sacrum And Coccyx Mal Neo Ribs/Stern/Clav Malignant Neoplasm Of Scapula And Long Bones Of Upper Limb Malignant Neoplasm Of Short Bones Of Upper Limb Mal Neo Pelvic Girdle Malignant Neoplasm Of Long Bones Of Lower Limb Malignant Neoplasm Of Short Bones Of Lower Limb Malignant Neoplasm Of Connective And Other Soft Tissue, Site Unspecified Malignant Neoplasm Of Connective And Other Soft Tissue Of Head, Face, And Neck Malignant Neoplasm Of Connective And Soft Tissue Upper Limb, Including Shoulder Malignant Neoplasm Of Connective And Soft Tissue Of Lower Limb, Including Hip Malignant Neoplasm Of Connective And Other Soft Tissue Of Trunk, Unspecified Malignant Neoplasm Of Connective And Other Soft Tissue Of Thorax Malignant Neoplasm Of Connective And Other Soft Tissue Of Abdomen Malignant Neoplasm Of Connective And Other Soft Tissue Of Pelvis Malignant Neoplasm Of Other Specified Sites Of Connective And Other Soft Tissue Last updated by CLO: 5/8/

12 Cancer Descriptions Unspecified Malignant Neoplasm Of Skin, Site Unspecified Unspecified Malignant Neoplasm Of Skin Of Lip Unspecified Malignant Neoplasm Of Eyelid, Including Canthus Unspecified Malignant Neoplasm Of Skin Of Ear And External Auditory Canal Unspecified Malignant Neoplasm Of Skin Of Other And Unspecified Parts Of Face Unspecified Malignant Neoplasm Of Scalp And Skin Of Neck Unspecified Malignant Neoplasm Of Skin Of Trunk, Except Scrotum Unspecified Malignant Neoplasm Of Skin Of Upper Limb, Including Shoulder Unspecified Malignant Neoplasm Of Skin Of Lower Limb, Including Hip Unspecified Malignant Neoplasm Of Other Specified Sites Of Skin Malignant Neoplasm Of Breast (Female), Unspecified Malignant Neoplasm Of Nipple And Areola Of Female Breast Malignant Neoplasm Of Central Portion Of Female Breast Malignant Neoplasm Of Upper-Inner Quadrant Of Female Breast Malignant Neoplasm Of Lower-Inner Quadrant Of Female Breast Malignant Neoplasm Of Upper-Outer Quadrant Of Female Breast Malignant Neoplasm Of Lower-Outer Quadrant Of Female Breast Malignant Neoplasm Of Axillary Tail Of Female Breast Malignant Neoplasm Of Other Specified Sites Of Female Breast Malignant Neoplasm Of Other And Unspecified Sites Of Male Breast Malignant Neoplasm Of Nipple And Areola Of Male Breast Malignant Neoplasm Of Female Genital Organ, Site Unspecified Malignant Neopl Placenta 181. Malig Neopl Uterus 179. Malignant Neoplasm Of Cervix Uteri, Unspecified Malig Neo Endocervix Malignant Neoplasm Of Exocervix Malignant Neoplasm Of Other Specified Sites Of Cervix Malignant Neoplasm Of Other Specified Sites Of Body Of Uterus Malignant Neoplasm Of Corpus Uteri, Except Isthmus Malignant Neoplasm Of Isthmus Malignant Neoplasm Of Uterine Adnexa, Unspecified Malignant Neoplasm Of Ovary Malignant Neoplasm Of Fallopian Tube Malignant Neoplasm Of Broad Ligament Of Uterus Malignant Neoplasm Of Parametrium Malignant Neoplasm Of Round Ligament Of Uterus Malignant Neoplasm Of Other Specified Sites Of Uterine Adnexa Malign Neopl Vagina Malignant Neoplasm Of Vulva, Unspecified Mal Neo Labia Majora Malignant Neoplasm Of Labia Minora Malignant Neoplasm Of Clitoris Malignant Neoplasm Of Other Specified Sites Of Female Genital Organs Malignant Neoplasm Of Male Genital Organ, Site Unspecified Malign Neopl Prostate 185. Malignant Neoplasm Of Other And Unspecified Testis Mal Neo Undescend Testis Malignant Neoplasm Of Penis, Part Unspecified Malignant Neoplasm Of Prepuce Malignant Neoplasm Of Glans Penis Malignant Neoplasm Of Body Of Penis Malignant Neoplasm Of Epididymis Malignant Neoplasm Of Spermatic Cord Malignant Neoplasm Of Scrotum Malignant Neoplasm Of Other Specified Sites Of Male Genital Organs Malignant Neoplasm Of Urinary Organ, Site Unspecified Malignant Neoplasm Of Bladder, Part Unspecified Last updated by CLO: 5/8/

13 Cancer Descriptions Malignant Neoplasm Of Trigone Of Urinary Bladder Malignant Neoplasm Of Dome Of Urinary Bladder Malignant Neoplasm Of Lateral Wall Of Urinary Bladder Malignant Neoplasm Of Anterior Wall Of Urinary Bladder Malignant Neoplasm Of Posterior Wall Of Urinary Bladder Malignant Neoplasm Of Bladder Neck Malignant Neoplasm Of Ureteric Orifice Malignant Neoplasm Of Urachus Malignant Neoplasm Of Other Specified Sites Of Bladder Malignant Neoplasm Of Kidney, Except Pelvis Malig Neo Renal Pelvis Malignant Neoplasm Of Ureter Malignant Neoplasm Of Urethra Malignant Neoplasm Of Paraurethral Glands Malignant Neoplasm Of Other Specified Sites Of Urinary Organs Malignant Neoplasm Of Eye, Part Unspecified Malignant Neoplasm Of Eyeball, Except Conjunctiva, Cornea, Retina, And Choroid Malign Neopl Orbit Malignant Neoplasm Of Lacrimal Gland Malignant Neoplasm Of Conjunctiva Malignant Neoplasm Of Cornea Malignant Neoplasm Of Retina Malignant Neoplasm Of Choroid Mal Neo Lacrimal Duct Malign Neopl Eye Other Malignant Neoplasm Of Nervous System, Part Unspecified Malignant Neoplasm Of Brain, Unspecified Malignant Neoplasm Of Cerebrum, Except Lobes And Ventricles Malignant Neoplasm Of Frontal Lobe Mal Neo Temporal Lobe Malignant Neoplasm Of Parietal Lobe Malignant Neoplasm Of Occipital Lobe Malignant Neoplasm Of Ventricles Mal Neo Cerebellum Mal Neo Brain Stem Malig Neo Brain Other Mal Neo Cranial Nerves Mal Neo Cerebral Mening Malignant Neoplasm Of Spinal Cord Mal Neo Spinal Meninges Malignant Neoplasm Of Other Specified Sites Of Nervous System Malignant Neoplasm Of Endocrine Gland, Site Unspecified Malign Neopl Thyroid 193. Malign Neopl Adrenal Malignant Neoplasm Of Pituitary Gland And Craniopharyngeal Duct Malignant Neoplasm Of Pineal Gland Malignant Neoplasm Of Carotid Body Malignant Neoplasm Of Aortic Body And Other Paraganglia Malignant Neoplasm Of Other Endocrine Glands And Related Structures Mal Neo Head/Face/Neck Malign Neopl Thorax Malignant Neoplasm Of Abdomen Malign Neopl Pelvis Malign Neopl Arm Malign Neopl Leg Malignant Neoplasm Of Other Specified Sites Secondary And Unspecified Malignant Neoplasm Of Lymph Nodes, Site Unspecified Mal Neo Lymph-Head/Neck Last updated by CLO: 5/8/

14 Cancer Descriptions Mal Neo Lymph-Intrathor Mal Neo Lymph Intra-Abd Mal Neo Lymph-Axilla/Arm Secondary Malignant Neoplasm Of Lymph Nodes Of Inguinal Region And Lower Limb Mal Neo Lymph-Intrapelv Mal Neo Lymph Node-Mult Secondary Malignant Neoplasm Of Lung Secondary Malignant Neoplasm Of Mediastinum Secondary Malignant Neoplasm Of Pleura Secondary Malignant Neoplasm Of Other Respiratory Organs Secondary Malignant Neoplasm Of Small Intestine Including Duodenum Secondary Malignant Neoplasm Of Large Intestine And Rectum Secondary Malignant Neoplasm Of Retroperitoneum And Peritoneum Malignant Neoplasm Of Liver, Specified As Secondary Secondary Malignant Neoplasm Of Other Digestive Organs And Spleen Secondary Malignant Neoplasm Of Kidney Sec Malig Neo Urin Other Secondary Malig Neo Skin Secondary Malignant Neoplasm Of Brain And Spinal Cord Sec Malig Neo Nerve Other Secondary Malignant Neoplasm Of Bone And Bone Marrow Secondary Malignant Neoplasm Of Adrenal Gland Secondary Malignant Neoplasm Of Breast Secondary Malignant Neoplasm Of Genital Organs Secondary Malignant Neoplasm Of Ovary Secondary Malignant Neoplasm Of Other Specified Sites Burkitt's Tumor Or Lymphoma, Unspecified Site, Extranodal And Solid Organ Sites Burkitt's Tumor Or Lymphoma Involving Lymph Nodes Of Head, Face, And Neck Burkitt's Tumor Or Lymphoma Involving Intrathoracic Lymph Nodes Burkitt's Tumor Or Lymphoma Involving Intra-Abdominal Lymph Nodes Burkitt's Tumor Or Lymphoma Involving Lymph Nodes Of Axilla And Upper Limb Burkitt's Tumor Or Lymphoma, Inguinal Region/Lower Limb Nodes Burkitt's Tumor Or Lymphoma Involving Intrapelvic Lymph Nodes Burkitt's Tumor Or Lymphoma Involving Spleen Burkitt's Tumor Or Lymphoma Involving Lymph Nodes Of Multiple Sites Other Icd9 Malignant Neoplasms, Lymphoid/Histiocytic, Extranodal/Solid Organs Malignant Mast Cell Tumors, Unspecified Site, Extranodal And Solid Organ Sites Malignant Mast Cell Tumors Involving Lymph Nodes Of Head, Face, And Neck Malignant Mast Cell Tumors Involving Intrathoracic Lymph Nodes Malignant Mast Cell Tumors Involving Intra-Abdominal Lymph Nodes Malignant Mast Cell Tumors Involving Lymph Nodes Of Axilla And Upper Limb Malignant Mast Cell Tumors Inguinal Region/Lower Limb Nodes Malignant Mast Cell Tumors Involving Intrapelvic Lymph Nodes Malignant Mast Cell Tumors Involving Spleen Malignant Mast Cell Tumors Involving Lymph Nodes Of Multiple Sites Other Icd9 Malignant Neoplasm, Lymphoid/Histiocytic Tissue Head/Face/Neck Nodes Other Icd9 Malignant Neoplasm, Lymphoid/Histiocytic Tissue Intrathoracic Nodes Other Icd9 Malignant Neoplasm, Lymphoid/Histiocytic Tissue Intra-Abdominal Nodes Other Icd9 Malignant Neoplasm, Lymphoid/Histiocytic Tissue Axilla/Upper Limb Other Icd9 Malignant Neoplasm Lymphoid/Histiocytic Inguinal Region/Lower Limb Other Icd9 Malignant Neoplasm Of Lymphoid/Histiocytic Tissue Intrapelvic Nodes Other Icd9 Malignant Neoplasms Of Lymphoid And Histiocytic Tissue Spleen Other Icd9 Malignant Neoplasms Of Lymphoid And Histiocytic Tissue Multiple Sites Other Immunoproliferative Neoplasms Without Mention Of Remission Benign Neoplasm Of Unspecified Site Last updated by CLO: 5/8/

15 Cancer Descriptions Benign Neoplasm Of Lymph Nodes Benign Neoplasm Of Other Specified Sites Benign Neoplasm Of Pharynx, Unspecified Benign Neoplasm Lip Benign Neoplasm Tongue Ben Neo Major Salivary Benign Neoplasm Of Floor Of Mouth Benign Neoplasm Of Other And Unspecified Parts Of Mouth Benign Neoplasm Of Tonsil Benign Neoplasm Of Other Parts Of Oropharynx Benign Neo Nasopharynx Benign Neo Hypopharynx Benign Neoplasm Of Other And Unspecified Site In The Digestive System Benign Neo Esophagus Benign Neoplasm Stomach Benign Neoplasm Of Duodenum, Jejunum, And Ileum Benign Neoplasm Lg Bowel Benign Neoplasm Of Rectum And Anal Canal Benign Neoplasm Of Liver And Biliary Passages Benign Neoplasm Of Pancreas, Except Islets Of Langerhans Ben Neo Islets Langerhan Benign Neoplasm Of Retroperitoneum And Peritoneum Benign Neoplasm Of Respiratory And Intrathoracic Organs, Site Unspecified Benign Neoplasm Of Nasal Cavities, Middle Ear, And Accessory Sinuses Benign Neo Larynx Benign Neoplasm Of Trachea Benign Neoplasm Of Bronchus And Lung Benign Neoplasm Pleura Benign Neo Mediastinum Benign Neoplasm Of Thymus Benign Neoplasm Of Heart Benign Neoplasm Of Other Specified Sites Of Respiratory And Intrathoracic Organs Benign Neoplasm Of Bone And Articular Cartilage, Site Unspecified Benign Neoplasm Of Bones Of Skull And Face Ben Neo Lower Jaw Bone Benign Neoplasm Of Vertebral Column, Excluding Sacrum And Coccyx Ben Neo Ribs/Stern/Clav Benign Neoplasm Of Scapula And Long Bones Of Upper Limb Benign Neoplasm Of Short Bones Of Upper Limb Benign Neo Pelvic Girdle Ben Neo Long Bones Leg Ben Neo Bones Ankle/Foot Other Benign Neoplasm Of Connective And Other Soft Tissue, Site Unspecified Benign Neoplasm Of Connective And Other Soft Tissue, Head, Face And Neck Benign Neoplasm Of Connective/Other Soft Tissue, Upper Limb, Including Shoulder Benign Neoplasm Of Connective/Other Soft Tissue, Lower Limb, Including Hip Other Benign Neoplasm Of Connective And Other Soft Tissue Of Thorax Other Benign Neoplasm Of Connective And Other Soft Tissue Of Abdomen Other Benign Neoplasm Of Connective And Other Soft Tissue Of Pelvis Other Benign Neoplasm Of Connective And Other Soft Tissue Of Trunk, Unspecified Other Icd9 Benign Neoplasm Of Connective And Other Soft Tissue Benign Neoplasm Of Skin, Site Unspecified Benign Neoplasm Of Skin Of Other And Unspecified Parts Of Face Benign Neoplasm Of Skin Of Lip Benign Neo Skin Eyelid Benign Neoplasm Of Ear And External Auditory Canal Benign Neoplasm Of Scalp And Skin Of Neck Benign Neoplasm Of Skin Of Trunk, Except Scrotum Last updated by CLO: 5/8/

16 Cancer Descriptions Benign Neoplasm Of Skin Of Upper Limb, Including Shoulder Benign Neoplasm Of Skin Of Lower Limb, Including Hip Benign Neoplasm Skin Other Benign Neoplasm Breast 217. Leiomyoma Of Uterus, (Fibroid Tumor) Benign Neoplasm Of Uterus, Part Unspecified Benign Neoplasm Of Cervix Uteri Benign Neo Corpus Uteri Benign Neoplasm Of Other Specified Parts Of Uterus Benign Neoplasm Of Female Genital Organ, Site Unspecified Benign Neoplasm Ovary 220. Ben Neo Fallopian Tube Benign Neoplasm Vagina Benign Neoplasm Vulva Ben Neo Fem Genital Other Benign Neoplasm Of Male Genital Organ, Site Unspecified Benign Neoplasm Of Testis Benign Neoplasm Penis Benign Neoplasm Of Prostate Benign Neoplasm Of Epididymis Benign Neoplasm Of Scrotum Benign Neoplasm Of Other Specified Sites Of Male Genital Organs Benign Neoplasm Of Urinary Organ, Site Unspecified Benign Neoplasm Of Kidney, Except Pelvis Benign Neoplasm Of Renal Pelvis Benign Neoplasm Of Ureter Benign Neoplasm Of Bladder Benign Neoplasm Of Urethra Benign Neoplasm Of Other Specified Sites Of Urinary Organs Benign Neoplasm Of Eye, Part Unspecified Benign Neoplasm Of Eyeball, Except Conjunctiva, Cornea, Retina, And Choroid Benign Neoplasm Of Orbit Benign Neoplasm Of Lacrimal Gland Benign Neoplasm Of Conjunctiva Benign Neoplasm Of Cornea Benign Neoplasm Of Retina Benign Neoplasm Of Choroid Ben Neo Lacrimal Duct Benign Neoplasm Of Other Specified Parts Of Eye Benign Neoplasm Of Nervous System, Part Unspecified Benign Neoplasm Brain Benign Neoplasm Of Cranial Nerves Ben Neo Cerebr Meninges Benign Neoplasm Of Spinal Cord Ben Neo Spinal Meninges Benign Neoplasm Of Other Specified Sites Of Nervous System Benign Neoplasm Thyroid 226. Benign Neoplasm Of Endocrine Gland, Site Unspecified Benign Neoplasm Of Adrenal Gland Benign Neoplasm Of Parathyroid Gland Benign Neoplasm Of Pituitary Gland And Craniopharyngeal Duct (Pouch) Benign Neoplasm Of Pineal Gland Benign Neoplasm Of Carotid Body Ben Neo Paraganglia Other Benign Neoplasm Of Other Endocrine Glands And Related Structures Carcinoma In Situ, Site Unspecified Carcinoma In Situ Of Eye Carcinoma In Situ Of Other Specified Sites Last updated by CLO: 5/8/

17 Cancer Descriptions Carcinoma In Situ Of Other And Unspecified Digestive Organs Ca In Situ Oral Cav/Phar Carcinoma In Situ Of Esophagus Carcinoma In Situ Of Stomach Carcinoma In Situ Of Rectum Carcinoma In Situ Of Anal Canal Carcinoma In Situ Of Anus, Unspecified Carcinoma In Situ Of Other And Unspecified Parts Of Intestine Carcinoma In Situ Of Colon Carcinoma In Situ Of Liver And Biliary System Carcinoma In Situ Of Respiratory System, Part Unspecified Carcinoma In Situ Of Larynx Carcinoma In Situ Of Trachea Carcinoma In Situ Of Bronchus And Lung Ca In Situ Resp Sys Other Carcinoma In Situ Of Skin, Site Unspecified Carcinoma In Situ Of Skin Of Other And Unspecified Parts Of Face Carcinoma In Situ Of Skin Of Lip Carcinoma In Situ Of Eyelid, Including Canthus Carcinoma In Situ Of Skin Of Ear And External Auditory Canal Carcinoma In Situ Of Scalp And Skin Of Neck Carcinoma In Situ Of Skin Of Trunk, Except Scrotum Carcinoma In Situ Of Skin Of Upper Limb, Including Shoulder Carcinoma In Situ Of Skin Of Lower Limb, Including Hip Carcinoma In Situ Of Other Specified Sites Of Skin Carcinoma In Situ Of Other And Unspecified Urinary Organs Carcinoma In Situ Of Breast Carcinoma In Situ Of Cervix Uteri Carcinoma In Situ Of Other And Unspecified Parts Of Uterus Carcinoma In Situ Of Prostate Carcinoma In Situ Of Penis Carcinoma In Situ Of Other And Unspecified Male Genital Organs Carcinoma In Situ Of Bladder Neoplasm Of Uncertain Behavior, Site Unspecified Unc Behav Neo Salivary Unc Behav Neo Oral/Phar Unc Behav Neo Intestine Neoplasm Of Uncertain Behavior Of Liver And Biliary Passages Neoplasm Of Uncertain Behavior Of Retroperitoneum And Peritoneum Unc Behav Neo Gi Other Unc Behav Neo Larynx Unc Behav Neo Lung Unc Behav Neo Pleura Neoplasm Of Uncertain Behavior Of Other And Unspecified Respiratory Organs Neoplasm Of Uncertain Behavior Of Testis Neoplasm Of Uncertain Behavior Of Prostate Neoplasm Of Uncertain Behavior Of Other And Unspecified Male Genital Organs Neoplasm Of Uncertain Behavior Of Uterus Neoplasm Of Uncertain Behavior Of Placenta Neoplasm Of Uncertain Behavior Of Ovary Neoplasm Of Uncertain Behavior Of Other And Unspecified Female Genital Organs Neoplasm Of Uncertain Behavior Of Urinary Organ, Unspecified Neoplasm Of Uncertain Behavior Of Bladder Neoplasm Of Uncertain Behavior Of Kidney And Ureter Neoplasm Of Uncertain Behavior Of Other Urinary Organs Unc Behav Neo Pituitary Neoplasm Of Uncertain Behavior Of Pineal Gland Neoplasm Of Uncertain Behavior Of Adrenal Gland Last updated by CLO: 5/8/

18 Cancer Descriptions Unc Behav Neo Paragang Neoplasm Of Uncertain Behavior Of Other And Unspecified Endocrine Glands Neoplasm Of Uncertain Behavior Of Brain And Spinal Cord Unc Behav Neo Meninges Neoplasm Of Uncertain Behavior Of Other And Unspecified Parts Of Nervous System Neoplasm Of Uncertain Behavior Of Bone And Articular Cartilage Neoplasm Of Uncertain Behavior Of Connective And Other Soft Tissue Neoplasm Of Uncertain Behavior Of Skin Neoplasm Of Uncertain Behavior Of Breast Neoplasm Of Uncertain Behavior Of Histiocytic And Mast Cells Neoplasm Of Uncertain Behavior Of Plasma Cells Neoplasm Of Uncertain Behavior Of Other Specified Sites Neoplasm Of Unspecified Nature, Site Unspecified Neoplasm Of Unspecified Nature Of Digestive System Neoplasm Of Unspecified Nature Of Respiratory System Bone/Skin Neoplasm Neoplasm Of Unspecified Nature Of Breast Neoplasm Of Unspecified Nature Of Bladder Neoplasm Of Unspecified Nature Of Other Genitourinary Organs Neoplasm Of Unspecified Nature Of Brain Neoplasm Of Unspecified Nature Of Endocrine Glands/Other Parts Of Nervous System Glaucoma Associated With Tumors Or Cysts Opt Chiasm W Pituit Dis Opt Chiasm Dis/Neopl Other Disorders Of Other Visual Pathways Associated With Neoplasms Vis Cortx Dis W Neoplasm Malignant Neoplasm Of Parathyroid Gland Other Immunoproliferative Neoplasms In Remission Giant Cell Tumor Tendon Osteitis Deformans Without Mention Of Bone Tumor Tumors Of Body Of Uterus, Unspecified As To Episode Of Care In Pregnancy Tumors Of Body Of Uterus, With Delivery Tumors Of Body Of Uterus, Delivered, With Mention Of Postpartum Complication Tumors Of Body Of Uterus, Antepartum Condition Or Complication Tumors Of Body Of Uterus, Postpartum Condition Or Complication Unspecified Personal History Of Malignant Neoplasm V10.90 Personal History Of Malignant Neoplasm In Gastrointestinal Tract V10.00 Personal History Of Malignant Neoplasm Of Oral Cavity And Pharynx V10.02 Personal History Of Malignant Neoplasm Of Tongue V10.01 Personal History Of Malignant Neoplasm Of Esophagus V10.03 Personal History Of Malignant Neoplasm Of Stomach V10.04 Personal History Of Malignant Neoplasm Of Large Intestine V10.05 Personal History Of Malignant Neoplasm Of Rectum, Rectosigmoid Junction, Anus V10.06 Personal History Of Malignant Neoplasm Of Liver V10.07 Personal History Of Malignant Neoplasm Of Other Sites In Gastrointestinal Tract V10.09 Personal History Of Malignant Neoplasm Of Unspecified Respiratory Organ V10.20 Personal History Of Malignant Neoplasm Of Bronchus And Lung V10.11 Personal History Of Malignant Neoplasm Of Trachea V10.12 Personal History Of Malignant Neoplasm Of Larynx V10.21 Personal History Of Malignant Neoplasm Of Nasal Cavities, Middle Ear, Sinuses V10.22 Personal History Of Malignant Neoplasm Of Other Respiratory/Intrathoracic Organs V10.29 Personal History Of Malignant Neoplasm Of Breast V10.3 Personal History Of Malignant Neoplasm Of Unspecified Female Genital Organ V10.40 Personal History Of Malignant Neoplasm Of Cervix Uteri V10.41 Personal History Of Malignant Neoplasm Of Other Parts Of Uterus V10.42 Personal History Of Malignant Neoplasm Of Ovary V10.43 Last updated by CLO: 5/8/

19 Cancer Descriptions Personal History Of Malignant Neoplasm Of Other Female Genital Organs V10.44 Personal History Of Malignant Neoplasm Of Unspecified Male Genital Organ V10.45 Personal History Of Malignant Neoplasm Of Prostate V10.46 Personal History Of Malignant Neoplasm Of Testis V10.47 Personal History Of Malignant Neoplasm Of Other Male Genital Organs V10.49 Personal History Of Malignant Neoplasm Of Unspecified Urinary Organ V10.50 Personal History Of Malignant Neoplasm Of Bladder V10.51 Personal History Of Malignant Neoplasm Of Kidney V10.52 Personal History Of Other Lymphatic And Hematopoietic Neoplasms V10.79 Personal History Of Malignant Neoplasm Of Bone V10.81 Personal History Of Other Malignant Neoplasm Of Skin V10.83 Personal History Of Malignant Neoplasm Of Eye V10.84 Personal History Of Malignant Neoplasm Of Brain V10.85 Personal History Of Malignant Neoplasm Of Other Parts Of Nervous System V10.86 Personal History Of Malignant Neoplasm Of Thyroid V10.87 Personal History Of Malignant Neoplasm, Other Endocrine Glands/Related Structure V10.88 Personal History Of Malignant Neoplasm Of Other Sites V10.89 Family History Of Unspecified Malignant Neoplasm V16.9 Family History Of Malignant Neoplasm Of Gastrointestinal Tract V16.0 Family History Of Malignant Neoplasm Of Trachea, Bronchus, And Lung V16.1 Family History Of Malignant Neoplasm Of Other Respiratory/Intrathoracic Organs V16.2 Family History Of Malignant Neoplasm Of Breast V16.3 Family History Of Malignant Neoplasm Of Genital Organs V16.40 Family History Of Other Lymphatic And Hematopoietic Neoplasms V16.7 Family History Of Other Specified Malignant Neoplasm V16.8 Observation For Suspected Malignant Neoplasm V71.1 Screening For Unspecified Malignant Neoplasms V76.9 Special Screening For Malignant Neoplasms Of The Respiratory Organs V76.0 Screening For Malignant Neoplasms Of The Breast V76.10 Screening For Malignant Neoplasms Of The Cervix V76.2 Screening For Malignant Neoplasms Of The Bladder V76.3 Screening For Malignant Neoplasms Of The Rectum V76.41 Screening For Malignant Neoplasms Of The Oral Cavity V76.42 Screening For Malignant Neoplasms Of The Skin V76.43 Screening For Malignant Neoplasms Of Other Sites V76.49 Injection Or Infusion Of Cancer Chemotherapeutic Substance Hyperthermia Ca Therapy Personal History Of Benign Neoplasm Brain V12.41 Family History Of Ovarian Malignancy V16.41 Family History Of Malignant Neoplasm Of Prostate V16.42 Family History Of Other Icd9 Genital Malignancy V16.49 Family History Of Malignancy Of Testis V16.43 Screening For Malignant Neoplasms Of The Breast In High-Risk Patients V76.11 Screening For Malignant Neoplasms Of The Breast In Other-Risk Patients V76.12 Screening For Other Icd9 Malignant Neoplasms Of The Breast V76.19 Personal History Of Malignant Neoplasm Of Epididymis V10.48 Family History Of Malignant Neoplasm Of Kidney V16.51 Screening For Malignant Neoplasms Of The Prostate V76.44 Screening For Malignant Neoplasms Of The Testis V76.45 Screening For Malignant Neoplasm Of Ovary V76.46 Screening For Malignant Neoplasm Of Vagina V76.47 Screening For Malignant Neoplasm Of Inestine V76.50 Screening For Malignant Neoplasm Of Colon V76.51 Screening For Malignant Neoplasm Of Small Intestine V76.52 Screening For Malignant Neoplasm Of Nervous System V76.81 Screening For Malignant Neoplasm, Not Elsewhere Classified V76.89 Anemia In Neoplastic Diseaes Last updated by CLO: 5/8/

20 Cancer Descriptions Personal History Of Malignant Neoplasm Of Other Urinary Organs V10.59 Aftercare Following Surgery For Neoplasm V58.42 Genetic Susceptibility To Malignant Neoplasm Of Breast V84.01 Genetic Susceptibility To Malignant Neoplasm Of Ovary V84.02 Genetic Susceptibility To Malignant Neoplasm Of Prostate V84.03 Genetic Susceptibility To Malignant Neoplasm Of Endometrium V84.04 Genetic Susceptibility To Other Malignant Neoplasm V84.09 Neoplasm Related Pain (Acute) (Chronic) Papanicolaou Smear Of Cervix With Cytologic Evidence Of Malignancy Elevated Cancer Antigen 125 [Ca 125] Other Abnormal Tumor Markers Carcinoma In Situ, Unspecified Female Genital Organ Carcinoma In Situ,Vagina Carcinoma In Situ,Vulva Carcinoma In Situ, Other Female Genital Organ Vulvar Intraepithelial Neoplasia I [Vin I] Vulvar Intraepithelial Neoplasia Ii [Vin Ii] Family History Of Malignant Neoplasm, Bladder V16.52 Yaba Monkey Tumor Virus Malignant Neoplasm Associated With Transplanted Organ Other Immunoproliferative Neoplasms In Relapse Malignant Carcinoid Tumor Of The Small Intestine, Unspecified Portion Malignant Carcinoid Tumor Of The Duodenum Malignant Carcinoid Tumor Of The Jejunum Malignant Carcinoid Tumor Of The Ileum Malignant Carcinoid Tumor Of The Large Intestine, Unspecified Portion Malignant Carcinoid Tumor Of The Appendix Malignant Carcinoid Tumor Of The Cecum Malignant Carcinoid Tumor Of The Ascending Colon Malignant Carcinoid Tumor Of The Transverse Colon Malignant Carcinoid Tumor Of The Descending Colon Malignant Carcinoid Tumor Of The Sigmoid Colon Malignant Carcinoid Tumor Of The Rectum Malignant Carcinoid Tumor Of Unknown Primary Site Malignant Carcinoid Tumor Of The Bronchus And Lung Malignant Carcinoid Tumor Of The Thymus Malignant Carcinoid Tumor Of The Stomach Malignant Carcinoid Tumor Of The Kidney Malignant Carcinoid Tumor Of The Foregut Nos Malignant Carcinoid Tumor Of The Midgut Nos Malignant Carcinoid Tumor Of The Hindgut Nos Malignant Carcinoid Tumors Of Other Sites Malignant Poorly Differentiated Neuroendocrine Carcinoma, Any Site Benign Carcinoid Tumor Of The Small Intestine, Unspecified Portion Benign Carcinoid Tumor Of The Duodenum Benign Carcinoid Tumor Of The Jejunum Benign Carcinoid Tumor Of The Ileum Benign Carcinoid Tumor Of The Large Intestine, Unspecified Portion Benign Carcinoid Tumor Of The Appendix Benign Carcinoid Tumor Of The Cecum Benign Carcinoid Tumor Of The Ascending Colon Benign Carcinoid Tumor Of The Transverse Colon Benign Carcinoid Tumor Of The Descending Colon Benign Carcinoid Tumor Of The Sigmoid Colon Benign Carcinoid Tumor Of The Rectum Benign Carcinoid Tumor Of Unknown Primary Site Benign Carcinoid Tumor Of The Bronchus And Lung Benign Carcinoid Tumor Of The Thymus Last updated by CLO: 5/8/

21 Cancer Descriptions Benign Carcinoid Tumor Of The Stomach Benign Carcinoid Tumor Of The Kidney Benign Carcinoid Tumor Of The Foregut Nos Benign Carcinoid Tumor Of The Midgut Nos Benign Carcinoid Tumor Of The Hindgut Nos Benign Carcinoid Tumors Of Other Sites Papanicolaou Smear Of Vagina With Cytologic Evidence Of Malignancy Papanicolaou Smear Of Anus With Cytologic Evidence Of Malignancy Merkel Cell Carcinoma Of The Face Merkel Cell Carcinoma Of The Scalp And Neck Merkel Cell Carcinoma Of The Upper Limb Merkel Cell Carcinoma Of The Lower Limb Merkel Cell Carcinoma Of The Trunk Merkel Cell Carcinoma Of Other Sites Secondary Neuroendocrine Tumor, Unspecified Site Secondary Neuroendocrine Tumor Of Distant Lymph Nodes Secondary Neuroendocrine Tumor Of Liver Secondary Neuroendocrine Tumor Of Bone Secondary Neuroendocrine Tumor Of Peritoneum Secondary Merkel Cell Carcinoma Secondary Neuroendocrine Tumor Of Other Sites Neoplasms Of Unspecified Nature, Retina And Choroid Neoplasms Of Unspecified Nature, Other Specified Sites Tumor Lysis Syndrome Personal History Of Malignant Neuroendocrine Tumor V10.91 Basal Cell Carcinoma Of Skin Of Lip Squamous Cell Carcinoma Of Skin Of Lip Other Specified Malignant Neoplasm Of Skin Of Lip Basal Cell Carcinoma Of Eyelid, Including Canthus Squamous Cell Carcinoma Of Eyelid, Including Canthus Other Specified Malignant Neoplasm Of Eyelid, Including Canthus Basal Cell Carcinoma Of Skin Of Ear And External Auditory Canal Squamous Cell Carcinoma Of Skin Of Ear And External Auditory Canal Other Specified Malignant Neoplasm Of Skin Of Ear And External Auditory Canal Basal Cell Carcinoma Of Skin Of Other And Unspecified Parts Of Face Squamous Cell Carcinoma Of Skin Of Other And Unspecified Parts Of Face Other Specified Malignant Neoplasm Of Skin Of Other And Unspecified Parts Of Face Basal Cell Carcinoma Of Scalp And Skin Of Neck Squamous Cell Carcinoma Of Scalp And Skin Of Neck Other Specified Malignant Neoplasm Of Scalp And Skin Of Neck Basal Cell Carcinoma Of Skin Of Trunk, Except Scrotum Squamous Cell Carcinoma Of Skin Of Trunk, Except Scrotum Other Specified Malignant Neoplasm Of Skin Of Trunk, Except Scrotum Basal Cell Carcinoma Of Skin Of Upper Limb, Including Shoulder Squamous Cell Carcinoma Of Skin Of Upper Limb, Including Shoulder Other Specified Malignant Neoplasm Of Skin Of Upper Limb, Including Shoulder Basal Cell Carcinoma Of Skin Of Lower Limb, Including Hip Squamous Cell Carcinoma Of Skin Of Lower Limb, Including Hip Other Specified Malignant Neoplasm Of Skin Of Lower Limb, Including Hip Basal Cell Carcinoma Of Other Specified Sites Of Skin Squamous Cell Carcinoma Of Other Specified Sites Of Skin Other Specified Malignant Neoplasm Of Other Specified Sites Of Skin Basal Cell Carcinoma Of Skin, Site Unspecified Squamous Cell Carcinoma Of Skin, Site Unspecified Other Specified Malignant Neoplasm Of Skin, Site Unspecified Lamberteaton Syndrome In Neoplastic Disease Last updated by CLO: 5/8/

82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung

82330 CALCIUM; IONIZED. ICD-10 Codes that Support Medical Necessity. ICD-10 Code. Description. A15.0 Tuberculosis of lung 82330 CALCIUM; IONIZED ICD-10 Codes that Support Medical Necessity ICD-10 Code Description A15.0 Tuberculosis of lung A15.4 Tuberculosis of intrathoracic lymph nodes A15.5 Tuberculosis of larynx, trachea

More information

Cancer Association of South Africa (CANSA)

Cancer Association of South Africa (CANSA) Cancer Association of South Africa (CANSA) Fact Sheet on ICD-10 Coding of Neoplasms Introduction The International Statistical Classification of Diseases and Related Health Problems, 10 th Revision (ICD-10)

More information

SCCA REFERENCE MANUAL ICD-10

SCCA REFERENCE MANUAL ICD-10 SCCA REFERENCE MANUAL ICD-10 NORTHWEST HOSPITAL 1 BREAST CANCER BREAST (INC. PAGET S DISEASE) 0 - Nipple and areola 1 - Central portion 2 - Upper-inner quadrant 3 - Lower-inner quadrant 4 - Upper-outer

More information

CEA (CARCINOEMBRYONIC ANTIGEN)

CEA (CARCINOEMBRYONIC ANTIGEN) (CARCINOEMBRYONIC ANTIGEN) 428 C15.3 Malignant neoplasm of upper third of esophagus C15.4 Malignant neoplasm of middle third of esophagus C15.5 Malignant neoplasm of lower third of esophagus C15.8 Malignant

More information

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to: DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not recorded =191 (non-melanoma skin cancer) treated as not recorded

More information

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:

WLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to: WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not

More information

Serum Iron Studies

Serum Iron Studies 190.18 - Serum Iron Studies Serum iron studies are useful in the evaluation of disorders of iron metabolism, particularly iron deficiency and iron excess. Iron studies are best performed when the patient

More information

Model Policy. Coverage of Proton Therapy

Model Policy. Coverage of Proton Therapy Model Policy Coverage of Proton Therapy Last Revised - February 2019 INTRODUCTION Proton therapy is a technologically advanced method to deliver curative radiation doses to cancerous tumors. The unique

More information

CLINICAL MEDICATION POLICY

CLINICAL MEDICATION POLICY Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICATION POLICY Granulocyte Colony Stimulating Factors (G-CSFs) MP-016-MD-DE Medical Management; Clinical Pharmacy Provider Notice Date:

More information

CLINICAL MEDICATION POLICY

CLINICAL MEDICATION POLICY Policy Name: Policy Number: Approved By: CLINICAL MEDICATION POLICY Keytruda (pembrolizumab) MP-014-MD-DE Medical Management; Clinical Pharmacy Provider Notice Date: 01/15/2018; 08/01/2017; 06/01/2016

More information

Contractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416)

Contractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416) Local Coverage Determination (LCD): Computerized Axial Tomography of the Chest/Thorax (L34416) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor

More information

Cancer in Estonia 2014

Cancer in Estonia 2014 Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National

More information

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary

155.2 Malignant neoplasm of liver not specified as primary or secondary. C22.9 Malignant neoplasm of liver, not specified as primary or secondary ICD-9 TO ICD-10 Reference ICD-9 150.9 Malignant neoplasm of esophagus unspecified site C15.9 Malignant neoplasm of esophagus, unspecified 151.9 Malignant neoplasm of stomach unspecified site C16.9 Malignant

More information

ICD-10 and Radiation Oncology

ICD-10 and Radiation Oncology ICD-10 and Radiation Oncology Steven M. Verno, CEMCS ICD-10 and Radiation Oncology Steven M. Verno, CEMCS September 23, 2008 Note: ICD-9-CM and ICD-10 are owned and copyrighted by the World Health Organization.

More information

MALIGNANT NEOPLASMS OF THE BREAST MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS

MALIGNANT NEOPLASMS OF THE BREAST MALIGNANT NEOPLASMS OF FEMALE GENITAL ORGANS MALIGNANT NEOPLASMS OF THE (INC. PAGET S DISEASE) 0 - Nipple and areola 1 - Central portion 2 - Upper-inner quadrant 3 - Lower-inner quadrant 4 - Upper-outer quadrant 5 - Lower-outer quadrant 6 - Axillary

More information

Genetic Testing for Cancer Susceptibility

Genetic Testing for Cancer Susceptibility Last Review Date: March 10, 2017 Number: MG.MM.AD.17v3 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Peripheral Nerve Blocks

Peripheral Nerve Blocks Last Review Date: April 21, 2017 Number: MG.MM.ME.64v2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

CLINICAL MEDICATION POLICY

CLINICAL MEDICATION POLICY CLINICAL MEDICATION POLICY Policy Name: Opdivo (nivolumab) injection Policy Number: Approved By: Medical Management, Clinical Pharmacy Products: Highmark Health Options Application: All participating hospitals

More information

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15

Crosswalk File of ICD9 Diagnosis Codes to Risk Group Assignment 1-Apr-15 1 1500 MALIGNANT NEOPLASM OF CERVICAL ESOPHAGUS 1 1501 MALIGNANT NEOPLASM OF THORACIC ESOPHAGUS 1 1502 MALIGNANT NEOPLASM OF ABDOMINAL ESOPHAGUS 1 1503 MALIGNANT NEOPLASM OF UPPER THIRD OF ESOPHAGUS 1

More information

Carcinoembryonic Antigen

Carcinoembryonic Antigen Other Names/Abbreviations CEA 190.26 - Carcinoembryonic Antigen Carcinoembryonic antigen (CEA) is a protein polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring

More information

Anatomical Considerations for Lab Practical II

Anatomical Considerations for Lab Practical II Anatomical Considerations for Lab Practical II For each of the following please be prepared to provide: Identification System Organ(s) or ducts to Function(s) location which it is attached Use your lecture

More information

Clinical Coding for CRS Standards

Clinical Coding for CRS Standards Clinical Coding for CRS Standards The following appendices set out the amended PRIMARY DIAGNOSIS coding structure to be used for the monitoring of cancer waiting times following the implementation of 4th

More information

DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY

DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY Date: 10 th April 2018 DATA REQUEST RESPONSE- XRT AND BRACHYTHERAPY Request: 1. Utilization Data of Overseas Beam Therapy and Brachytherapy 2. Diagnoses Data of Overseas Claims for Beam Therapy and Brachytherapy

More information

Intensity Modulated Radiation Therapy (IMRT)

Intensity Modulated Radiation Therapy (IMRT) Intensity Modulated Radiation Therapy (IMRT) [For the list of services and procedures that need preauthorization, please refer to www.mcs.com.pr go to Comunicados a Proveedores, and click Cartas Circulares.]

More information

ANNUAL CANCER REGISTRY REPORT-2005

ANNUAL CANCER REGISTRY REPORT-2005 ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males

More information

S2 File. Clinical Classifications Software (CCS). The CCS is a

S2 File. Clinical Classifications Software (CCS). The CCS is a S2 File. Clinical Classifications Software (CCS). The CCS is a diagnosis categorization scheme based on the ICD-9-CM that aggregates all diagnosis codes into 262 mutually exclusive, clinically homogeneous

More information

Colony Stimulating Factors: Neupogen (filgrastim), Neulasta (pegfilgrastim), Leukine (sargramostim), Granix (tbo-filgrastim)

Colony Stimulating Factors: Neupogen (filgrastim), Neulasta (pegfilgrastim), Leukine (sargramostim), Granix (tbo-filgrastim) Neupogen (filgrastim), Neulasta (sargramostim), Granix (tbo-filgrastim) Date of Origin: 10/17/2008 Dates Reviewed: 6/17/2009, 12/22/2009, 06/15/2010/ 7/20/2010, 09/2010, 12/2010, 03/2011, 06/2011, 09/2011,

More information

Pembrolizumab (Keytruda )

Pembrolizumab (Keytruda ) Last Review Date: March 14, 2017 Number: MG.MM.PH.10f Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

SITES (ALPHABETICAL) HPV CS SITE SPECIFIC FACTOR

SITES (ALPHABETICAL) HPV CS SITE SPECIFIC FACTOR SITES (ALPHABETICAL) HPV CS SITE SPECIFIC FACTOR Anus: Anal Canal; Anus, NOS; Other Parts of Rectum C21.0-C21.2, C21.8 C21.0 Anus, NOS (excludes skin of anus and perianal skin C44.5) C21.1 Anal canal C21.2

More information

Contractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography (CT), Thorax (L33459) Document Information

Contractor Information. LCD Information. Local Coverage Determination (LCD): Computerized Axial Tomography (CT), Thorax (L33459) Document Information Local Coverage Determination (LCD): Computerized Axial Tomography (CT), Thorax (L33459) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information

More information

Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green

Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green Group B: Organ systems (digestive, respiratory, urinary, genital system, heart, glands and skin) green Digestive system 1. Teeth Main points: external and internal structure of a tooth, fixation of a tooth

More information

Fentora (Fentanyl Buccal)

Fentora (Fentanyl Buccal) Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Fentora (Fentanyl Buccal) Clinical Edit Information Included in this Document Fentora 100mcg Drugs requiring prior authorization:

More information

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill

2011 to 2015 New Cancer Incidence Truman Medical Center - Hospital Hill Number of New Cancers Truman Medical Center Hospital Hill Cancer Registry 2015 Statistical Summary Incidence In 2015, Truman Medical Center diagnosed and/or treated 406 new cancer cases. Four patients

More information

CLINICAL MEDICAL POLICY

CLINICAL MEDICAL POLICY Policy Name: Policy Number: Responsible Department(s): CLINICAL MEDICAL POLICY Opdivo (nivolumab) MP-004-MC-PA Medical Management; Clinical Pharmacy Provider Notice Date: 09/01/2018; 06/15/2018; 04/01/2017

More information

END-SEMESTER EXAM 2018 ANATOMY, HISTOLOGY AND EMBRYOLOGY FACULTY OF MEDICINE, 2 ND SEMESTER

END-SEMESTER EXAM 2018 ANATOMY, HISTOLOGY AND EMBRYOLOGY FACULTY OF MEDICINE, 2 ND SEMESTER University of Szeged, Faculty of Medicine Department of Anatomy, Histology and Embryology Chairman: Prof. Antal Nógrádi MD, PhD, DSc Kossuth L. sgt. 40., H-6724 Szeged, Hungary Tel.: +36-62-545-665 P.

More information

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care.

Annual Report. Cape Cod Hospital and Falmouth Hospital Regional Cancer Network Expert physicians. Quality hospitals. Superior care. Annual Report Cape Cod Hospital and Falmouth Hospital Regional Cancer Network 2013 Expert physicians. Quality hospitals. Superior care. Cape Cod Hospital s Davenport- Mugar Hematology/Oncology Center and

More information

ACTIVITY 11: RESPIRATORY AND DIGESTIVE SYSTEMS RESPIRATORY SYSTEM

ACTIVITY 11: RESPIRATORY AND DIGESTIVE SYSTEMS RESPIRATORY SYSTEM ACTIVITY 11: RESPIRATORY AND DIGESTIVE SYSTEMS OBJECTIVES: 1) How to get ready: Read Chapters 25 and 26, McKinley et al., Human Anatomy, 4e. All text references are for this textbook. 2) Identify structures

More information

RESPIRATORY SYSTEM. described: pp. 744,746 fig. 25.1, described: p. 746 fig described: p. 776 fig. 26.3

RESPIRATORY SYSTEM. described: pp. 744,746 fig. 25.1, described: p. 746 fig described: p. 776 fig. 26.3 ACTIVITY 11: RESPIRATORY AND DIGESTIVE SYSTEMS OBJECTIVES: 1) How to get ready: Read Chapters 25 and 26, McKinley et al., Human Anatomy, 5e. All text references are for this textbook. 2) Identify structures

More information

Anatomy. Contents Brain (Questions)

Anatomy. Contents Brain (Questions) Anatomy 12 Contents 12.1 Brain (Questions).................................................... 683 12.2 Head and Neck (Questions)............................................. 685 12.3 Thorax (Questions)...................................................

More information

Gamma Glutamyl Transferase

Gamma Glutamyl Transferase Other Names/Abbreviations GGT 190.32 - Gamma Glutamyl Transferase Gamma glutamyl transferase (GGT) is an intracellular enzyme that appears in blood following leakage from cells. Renal tubules, liver, and

More information

General Anatomy p. 1 Organization of the Human Body p. 1 Skeleton of the Human Body p. 4 Ossification of the Bones p. 6 Bone Structure p. 8 Joints p.

General Anatomy p. 1 Organization of the Human Body p. 1 Skeleton of the Human Body p. 4 Ossification of the Bones p. 6 Bone Structure p. 8 Joints p. General Anatomy p. 1 Organization of the Human Body p. 1 Skeleton of the Human Body p. 4 Ossification of the Bones p. 6 Bone Structure p. 8 Joints p. 10 Principal Joints (Immovable) p. 12 Synovial Joints

More information

Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information

Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor

More information

NEW/REVISED MATERIAL: Presented in italicized text EFFECTIVE DATE: January 1, 2008 GUIDELINES FOR REPORTING ADMINISTRATION OF EPOGEN MEDICARE

NEW/REVISED MATERIAL: Presented in italicized text EFFECTIVE DATE: January 1, 2008 GUIDELINES FOR REPORTING ADMINISTRATION OF EPOGEN MEDICARE DISCLAIMER: Please be advised that while every effort has been made to ensure the accuracy of the information provided according to the most current LCD pertaining to the subject, periodic change to rules

More information

REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after

REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2015 and after The following lists are intended to assist you, as the reporter, in identifying the reportable neoplasms for your facility. Any reportable

More information

This lab activity is aligned with Visible Body s Human Anatomy Atlas app. Learn more at visiblebody.com/professors

This lab activity is aligned with Visible Body s Human Anatomy Atlas app. Learn more at visiblebody.com/professors 1 This lab activity is aligned with Visible Body s Human Anatomy Atlas app. Learn more at visiblebody.com/professors 2 A. Digestive System Overview To Start: Go to the Views menu and scroll down to the

More information

Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information

Contractor Information. LCD Information. Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Document Information Local Coverage Determination (LCD): CT of the Abdomen and Pelvis (L34415) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information Contractor

More information

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional

More information

Descriptive Histology

Descriptive Histology Atlas of Descriptive Histology Michael H. Ross University of Florida College of Medicine Gainesville, Florida Wojciech Pawlina Mayo Medical School College of Medicine, Mayo Clinic Rochester, Minnesota

More information

Introduction to ICD-O-3 coding rules

Introduction to ICD-O-3 coding rules Introduction to ICD-O-3 coding rules Weena Laddachayaporn, MD National Cancer Institute, Bangkok, Thailand ICD-O-3 The International Classification of Diseases for Oncology Is a coding system for primary

More information

BRAF Mutation Analysis

BRAF Mutation Analysis Last Review Date: October 13, 2017 Number: MG.MM.LA.38aC Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Florida Cancer Data System STAT File Documentation Version 2019

Florida Cancer Data System STAT File Documentation Version 2019 Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status

More information

2012 Cancer Report 2011 Registry Data

2012 Cancer Report 2011 Registry Data 2012 Cancer Report 2011 Registry Data Contents Goals and Objectives 1 2012 Cancer Committee Members 2 Total Cancer Cases 1981-2011 3 Cancer Registry Frequency Report 1981-2011 4-5 Cancer Registry Frequency

More information

Neoplasms/Lymphoma/Leukemia

Neoplasms/Lymphoma/Leukemia Neoplasms/Lymphoma/Leukemia Session Guidelines This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and

More information

Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute

Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute Globally Optimal Statistical Classification Models, I: Binary Class Variable, One Ordered Attribute Paul R. Yarnold, Ph.D. and Robert C. Soltysik, M.S. Optimal Data Analysis, LLC Imagine a random sample

More information

SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl

SEER Advanced Topic 2018 Presentation. EOD 2018 and SS2018 Jennifer Ruhl SEER Advanced Topic 2018 Presentation EOD 2018 and SS2018 Jennifer Ruhl May 25, 2018 Outline General overview of EOD Schemas Basic review of what is needed to collect Primary Tumor, Regional Nodes and

More information

Human Anatomy & Physiology. Introduction (Ch. 1)

Human Anatomy & Physiology. Introduction (Ch. 1) Human Anatomy & Physiology Introduction (Ch. 1) Overview of Anatomy and Physiology Anatomy the study of the structure of body parts and their relationships to one another Gross or macroscopic Microscopic

More information

RAMATHIBODI CANCER REPORT

RAMATHIBODI CANCER REPORT RAMATHIBODI CANCER REPORT 2016 Ramathibodi Cancer Registry : A subsidiary of Ramathibodi Comprehensive Cancer Center Faculty of Medicine, Ramathibodi Hospital Mahidol University Table of content INTRODUCTION...III

More information

Lungs a. d. b. c. e.

Lungs a. d. b. c. e. Lungs d. e. Lungs Right superior lobe Right middle lobe Right inferior lobe d. Left superior lobe e. Left inferior lobe Sinuses d. Nasal Cavity & Sinuses g. g. i. Nasal Cavity & Sinuses g. h. d. f. e.

More information

John R. Marsh Cancer Center

John R. Marsh Cancer Center John R. Marsh Cancer Center Lung Program Overview: 2014-2015 Initiatives Lung CT Screening Dr. Gregory Zimmerman In cooperation with The Lung Cancer Steering Committee, Diagnostic Imaging Services at the

More information

Lab 5 Digestion and Hormones of Digestion. 7/16/2015 MDufilho 1

Lab 5 Digestion and Hormones of Digestion. 7/16/2015 MDufilho 1 Lab 5 Digestion and Hormones of Digestion 1 Figure 23.1 Alimentary canal and related accessory digestive organs. Mouth (oral cavity) Tongue* Parotid gland Sublingual gland Submandibular gland Salivary

More information

OVARIES URETER FALLOPIAN TUBES BLADDER UROGENITAL OPENINGS (BOTH SEXES) PENIS VAGINA UTERUS

OVARIES URETER FALLOPIAN TUBES BLADDER UROGENITAL OPENINGS (BOTH SEXES) PENIS VAGINA UTERUS URETER OVARIES FALLOPIAN TUBES BLADDER UROGENITAL OPENINGS (BOTH SEXES) PENIS VAGINA UTERUS REPRODUCTIVE PRODUCE FEMALE HORMONES EXCRETORY FROM KIDNEY TO BLADDER EXCRETORY STORES URINE REPRODUCTIVE TRANSPORTS

More information

APPENDIX ONE: ICD CODES

APPENDIX ONE: ICD CODES APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding

More information

Jhia Anjela D. Rivera 1 1. BS Biology, Department of Biology, College of Science, Polytechnic University of the Philippines

Jhia Anjela D. Rivera 1 1. BS Biology, Department of Biology, College of Science, Polytechnic University of the Philippines DIGESTIVE SYSTEM Jhia Anjela D. Rivera 1 1 BS Biology, Department of Biology, College of Science, Polytechnic University of the Philippines DIGESTIVE SYSTEM Consists of the digestive tract (gastrointestinal

More information

Digestive System. In one end and out the other.

Digestive System. In one end and out the other. Digestive System In one end and out the other. Overview Every cell in the body needs nourishment, yet most cells cannot leave their position in the body and travel to a food source, so the food must be

More information

Anatomy: Know Your Abdomen

Anatomy: Know Your Abdomen Anatomy: Know Your Abdomen Glossary Abdomen - part of the body below the thorax (chest cavity); separated by the diaphragm. Anterior - towards the front of the body. For example, the umbilicus is anterior

More information

CODING PRIMARY SITE. Nadya Dimitrova

CODING PRIMARY SITE. Nadya Dimitrova CODING PRIMARY SITE Nadya Dimitrova OUTLINE What is coding and why do we need it? ICD-10 and ICD-O ICD-O-3 Topography coding rules ICD-O-3 online WHAT IS CODING AND WHY DO WE NEED IT? Coding: to assign

More information

Khapzory (levoleucovorin) (Intravenous)

Khapzory (levoleucovorin) (Intravenous) Khapzory (levoleucovorin) (Intravenous) Last Review Date: 12/04/2018 Date of Origin: 12/04/2018 Dates Reviewed: 12/2018 Document Number: IC-0408 I. Length of Authorization Coverage will be provided for

More information

Cardiovascular Digestive. Endocrine Integumentary

Cardiovascular Digestive. Endocrine Integumentary General Anatomy Match the Components and Functions with their respective primary Anatomical System COMPONENTS / DESCRIPTION CODE Anatomical System Primary Function 1. Fallopian tubes and seminal vesicles

More information

Respiratory & Digestive Organs of the Head and Neck, Human;

Respiratory & Digestive Organs of the Head and Neck, Human; Name Date Lab Exercise 5: Lab Exercise 6: Lab Exercise 7: Lab Exercise 8: Respiratory & Digestive Organs of the Head and Neck, Human; Histology of the Respiratory System Digestive System Models, Human

More information

SHN-1 Human Digestive Panel Test results

SHN-1 Human Digestive Panel Test results SHN-1 Human Digestive Panel Test results HN-30 tongue HN-24 salivary gland HN-12 larynx HN-28 esophagus HN-29 stomach HN-20 pancreas HN-13 liver HN-14 gall bladder HN-27-1 duodenum HN-27-2 ileum HN-27-3

More information

Body Regions Review. Anatomical Position. Anatomical Planes. Supine versus Prone 9/9/2009

Body Regions Review. Anatomical Position. Anatomical Planes. Supine versus Prone 9/9/2009 Body Regions Review The fundamental divisions of the human body Christine Sparks Anatomy / Physiology I Sept. 9, 2009 Anatomical Position Universal terms are used to describe the body accurately and result

More information

All Discovered Death Outcome Detail (Form 124/120)

All Discovered Death Outcome Detail (Form 124/120) This file includes all reported deaths regardless of consent. ID WHI Common ID Col#1 DEATHALL All Discovered Death Col#2 Any report of death, regardless of consent status. 0 No 106,931 66.1 1 Yes 54,877

More information

Fusilev (levoleucovorin) Document Number: IC-0183

Fusilev (levoleucovorin) Document Number: IC-0183 Fusilev (levoleucovorin) Document Number: IC-0183 Last Review Date: 2/1/2018 Date of Origin: 01/02/2014 Dates Reviewed: 08/2014, 03/2015, 05/2015, 08/2015, 11/2015, 02/2016, 05/2016, 08/2016, 11/2016,

More information

Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies

Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies Web appendix 2: SEARCH STRATEGIES Interventions for non-metastatic squamous cell carcinoma of the skin: a systematic review and pooled analysis of observational studies MEDLINE 1. exp epidemiologic studies/

More information

California Cancer Registry Production Automation and Quality Control Unit Data Alert - Registrar

California Cancer Registry Production Automation and Quality Control Unit Data Alert - Registrar Production Automation and Quality Control Unit Data Alert - Registrar 2015-061 REVISED Casefinding List FY2016 Please see additions and revisions noted below in red text. ICD-10-CM Codes have been adopted

More information

Alpha-fetoprotein

Alpha-fetoprotein Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain

More information

Section 2 - Musculo-skeletal System. A list of the first 3 digits - 72 terms

Section 2 - Musculo-skeletal System. A list of the first 3 digits - 72 terms 1 Section 2 - Musculo-skeletal System A list of the first - 72 terms Index + Regional terms 2 MUSCULOSKELETAL SYSTEM 20 Musculoskeletal system: general terms 201 Skeletal system 202 Muscular system: types

More information

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site POLICY: PG0364 ORIGINAL EFFECTIVE: 04/22/16 LAST REVIEW: 07/26/18 MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site GUIDELINES This policy does not certify benefits or authorization

More information

Fig. A.1. Frontal. plane. Transverse. plane. Sagittal plane. Copyright McGraw-Hill Education. Permission required for reproduction or display.

Fig. A.1. Frontal. plane. Transverse. plane. Sagittal plane. Copyright McGraw-Hill Education. Permission required for reproduction or display. Fig. A.1 Frontal plane Transverse plane Sagittal plane McGraw-Hill Education/Joe DeGrandis Fig. A.2 (a) Sagittal section (b) Frontal section (c) Transverse section Table A.1 Fig. A.3 Cephalic r. (head)

More information

2017 ICD-10-CM Casefinding List (Abbreviated listing from SEER website) COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors

2017 ICD-10-CM Casefinding List (Abbreviated listing from SEER website) COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors 2017 ICD-10-CM Casefinding List (Abbreviated listing from SEER website) COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors ICD-10 Code Explanation of Code Malignant neoplasms (excluding

More information

A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files

A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files By Dr. Martin A. Whiteside Director, Office of Cancer

More information

Alpha-fetoprotein

Alpha-fetoprotein Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain

More information

BIO 137 Human Anatomy & Physiology I. Laboratory Manual. Laboratory #1: Measurements, Body Organization and Anatomical Systems

BIO 137 Human Anatomy & Physiology I. Laboratory Manual. Laboratory #1: Measurements, Body Organization and Anatomical Systems BIO 137 Human Anatomy & Physiology I Laboratory Manual Laboratory #1: Measurements, Body Organization and Anatomical Systems Lab Exercise 1 Measurements Body Organization Body Systems What you need to

More information

incidence rate x 100,000/year

incidence rate x 100,000/year Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European

More information

RADPrimer Curriculum Breast Topics Covered Basic Intermediate 225

RADPrimer Curriculum Breast Topics Covered Basic Intermediate 225 Breast Anatomy & Normal Variants 11 Breast Imaging Modalities 13 BI RADS Lexicon 3 Mammography: Masses 9 Mammography: Calcifications 17 Mammography: Additional Findings 8 Ultrasound Features 10 Ultrasound

More information

Date Lab Pd. Lecture Notes (57)

Date Lab Pd. Lecture Notes (57) Name SECTION OBJECTIVES Describe the locations of the major body cavities List the organs located in each major body cavity Name the membranes associated with the thoracic and abdominopelvic cavities Name

More information

3 Circulatory Pathways

3 Circulatory Pathways 40 Chapter 3 Circulatory Pathways Systemic Arteries -Arteries carry blood away from the heart to the various organs of the body. -The aorta is the longest artery in the body; it branches to give rise to

More information

Biology Human Anatomy Abdominal and Pelvic Cavities

Biology Human Anatomy Abdominal and Pelvic Cavities Biology 351 - Human Anatomy Abdominal and Pelvic Cavities Please place your name and I.D. number on the back of the last page of this exam. You must answer all questions on this exam. Because statistics

More information

TABLE OF SPECIFICATIONS M. PHIL ANATOMY SUMMARY. MCQs: Marks SEQs: Marks. Segment MCQs SEQs

TABLE OF SPECIFICATIONS M. PHIL ANATOMY SUMMARY. MCQs: Marks SEQs: Marks. Segment MCQs SEQs M. PHIL ANATOMY SUMMARY MCQs: 150 150 Marks SEQs: 15 150 Marks Segment MCQs SEQs Gross Anatomy 35% 35% Microanatomy (Histology) 25% 25% Neuroanatomy 20% 20% Embryology 20% 20% GROSS ANATOMY Table of specification

More information

Microscopic Anatomy Cytology study of the cell Histology study of tissues

Microscopic Anatomy Cytology study of the cell Histology study of tissues Introduction to Anatomy and Physiology Dr. Gary Mumaugh Overview of Anatomy and Physiology Anatomy the study of the structure of body parts and their relationships to one another o Gross or macroscopic

More information

Overview of Anatomy & Physiology

Overview of Anatomy & Physiology Overview of Anatomy & Physiology Anatomy the study of the structure of body parts and their relationships to one another Gross or macroscopic Microscopic Developmental Physiology the study of the function

More information

Keytruda (pembrolizumab) (Intravenous)

Keytruda (pembrolizumab) (Intravenous) Keytruda (pembrolizumab) (Intravenous) Last Review Date: 02/06/2018 Date of Origin: 09/30/2014 Document Number: IC-0209 Dates Reviewed: 9/2014, 3/2015, 5/2015, 8/2015, 10/2015, 11/2015, 2/2016, 5/2016,

More information

Sample page. Surgical. Cross Coder. Essential links from CPT codes to ICD-10-CM and HCPCS

Sample page. Surgical. Cross Coder. Essential links from CPT codes to ICD-10-CM and HCPCS Cross Coder 2018 Surgical Essential links from CPT codes to ICD-10-CM and HCPCS POWER UP YOUR CODING with Optum360, your trusted coding partner for 32 years. Visit optum360coding.com. Contents Introduction...

More information

Alpha-fetoprotein

Alpha-fetoprotein Other Names/Abbreviations AFP 190.25 - Alpha-fetoprotein Alpha-fetoprotein (AFP) is a polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring the response of certain

More information

2016 Cancer Registry Annual Report

2016 Cancer Registry Annual Report 2016 Cancer Registry Annual Report Cancer Committee Chairman s Report The Cancer Committee at Cancer Treatment Centers of America (CTCA) at Eastern Regional Medical Center (Eastern), established in 2006,

More information

REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2017 and after

REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2017 and after REPORTABLE CASES MISSISSIPPI For cases diagnosed 10/1/2017 and after The following lists are intended to assist you, as the reporter, in identifying the reportable neoplasms for your facility. Any reportable

More information

SYLLABUS BDS I PROFESSIONAL GENERAL HUMAN ANATOMY INCLUDING EMBRYOLOGY AND HISTOLOGY

SYLLABUS BDS I PROFESSIONAL GENERAL HUMAN ANATOMY INCLUDING EMBRYOLOGY AND HISTOLOGY GENERAL HUMAN ANATOMY INCLUDING EMBRYOLOGY AND HISTOLOGY I. General Anatomy 1. Anatomical terms 2. Skin, superficial fascia & deep fascia 3. Cardiovascular system, portal system, collateral circulation

More information

SUBJECTS 2nd year, 1st semester I. 1. Primitive gut - limits, derivatives 2. Foregut -limits, evolution, derivatives 3. Midgut -limits, evolution,

SUBJECTS 2nd year, 1st semester I. 1. Primitive gut - limits, derivatives 2. Foregut -limits, evolution, derivatives 3. Midgut -limits, evolution, SUBJECTS 2nd year, 1st semester I. 1. Primitive gut - limits, derivatives 2. Foregut -limits, evolution, derivatives 3. Midgut -limits, evolution, derivatives 4. Hindgut- limits, evolution, derivatives

More information

7/4/2018. Key Objectives. A and P 2401 Lecture 2 TWO MECHANISMS USED TO MAINTAIN HOMEOSTASIS. Negative Feedback Examples. Review of Homeostasis

7/4/2018. Key Objectives. A and P 2401 Lecture 2 TWO MECHANISMS USED TO MAINTAIN HOMEOSTASIS. Negative Feedback Examples. Review of Homeostasis Key Objectives Review of Homeostasis Negative Feedback Mechanisms Positive Feedback Mechanisms Body Systems and Function A and P 2401 Lecture 2 HOMEOSTASIS TWO MECHANISMS USED TO MAINTAIN HOMEOSTASIS The

More information

Nov FromAtoZCodesMatter

Nov FromAtoZCodesMatter Nov 2017 FromAtoZCodesMatter From A to Z-Codes Matter Susan Wallace, MEd, RHIA, CCS, CDIP, CCDS, FAHIMA The implementation of ICD-10 brought tens of thousands of new codes. Ranging from A to Z, they portray

More information